The global demand for Blood and Blood Components Market is presumed to reach the market size of nearly USD 25.4 Billion by 2032 from USD 17.96 Billion in 2023 with a CAGR of 3.93% under the study period 2024-2032.
Blood and blood components refer to whole blood and its separated components, such as red blood cells, white blood cells, platelets, and plasma, used in medical treatments. These components are critical for various therapeutic purposes, including transfusions for patients with anemia, clotting disorders, trauma, and surgical procedures. Blood components are carefully matched to the recipient's blood type to ensure compatibility and safety. The separation of blood into its components allows for targeted treatments, optimizing the use of donated blood and improving patient outcomes in various clinical settings.
The rising incidence of trauma cases, surgical procedures, and chronic diseases necessitates the use of blood and blood components to manage patients' conditions effectively. Additionally, the aging global population, more susceptible to medical conditions requiring blood transfusions, significantly boosts the market. Advancements in blood collection, processing, and storage technologies are enhancing the safety and efficiency of blood and blood components, further driving their demand. The increasing awareness about blood donation and government initiatives to encourage voluntary blood donation are also significant factors propelling the market. Furthermore, the development of advanced screening and testing methods to ensure the safety of blood and blood components contributes to market growth. The rise in the number of hospitals, blood banks, and healthcare facilities globally is expanding the availability and accessibility of these critical products. However, the risk of transfusion-transmitted infections and the high cost of blood processing and storage may challenge market growth in the coming years.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Blood and Blood Components. The growth and trends of Blood and Blood Components industry provide a holistic approach to this study.
This section of the Blood and Blood Components market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
By Application
By End-Use
This section covers the regional outlook, which accentuates current and future demand for the Blood and Blood Components market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Blood and Blood Components market include European Blood Alliance, Australian Red Cross, Indian Red Cross, American Association Of Blood Banks, South African National Blood Service. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1. PREFACE
1.1. Report Description
1.1.1 Objective
1.1.2 Target Audience
1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1 Market Research Process
1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3. BLOOD AND BLOOD COMPONENTS – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By End-Use
3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY PRODUCT
5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Whole Blood Historic and Forecast Sales By Regions
5.4. Blood Components (Red blood cells, Platelets, Plasma, White Blood Cells) Historic and Forecast Sales By Regions
6. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY APPLICATION
6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Anaemia Historic and Forecast Sales By Regions
6.4. Trauma & Surgery Historic and Forecast Sales By Regions
6.5. Cancer Treatment Historic and Forecast Sales By Regions
6.6. Bleeding Disorders Historic and Forecast Sales By Regions
6.7...
